A series of novel
N3,
N11-bis(2-hydroxyethyl)-14-aryl-14
H-dibenzo[
a,
j]xanthenes-3,11-dicarboxamide, three
N3,
N11-bis(2-hydroxyethyl)-14-aryl-14
H-dibenzo[
a,
j]xanthene-3,11-dimethanamine derivatives and their intermediates 14-aryl-14
H-dibenzo[
a,
j]xanthenes-3,11-dicarboxylic acid, were synthesized, and the structures of which were characterized by
1H-NMR,
13C-NMR, high resolution (HR)-MS, and IR spectra. The antitumor activities of these molecules were evaluated on five cancer cell lines. The results of
in vitro assay against human hepatocellular carcinoma cell lines (SK-HEP-1 and HepG2 and SMMC-7721 cells), acute promyelocytic leukemia NB4 cells and uterine cervix cancer HeLa cells, show several compounds to be endowed with cytotoxicity in micromolar to submicromolar range. The carboxamide derivatives
6c and
6e exhibitted good inhibition on NB4 cancer cells, and the IC
50 values of which were 0.82 µ
M and 0.96 µ
M, respectively, much lower than 5.01 µ
M of the positive control As
2O
3. Flow cytometric analysis results revealed that compounds
6e and
6f may induce tumor cell apoptosis.
View full abstract